Edgar Lomax Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.2M | Buy |
70,108
+49,260
| +236% | +$10.9M | 1.09% | 39 |
|
|
2025
Q4 | $4.76M | Sell |
20,848
-505
| -2% | -$115K | 0.36% | 51 |
|
|
2025
Q3 | $4.94M | Sell |
21,353
-6,265
| -23% | -$1.28M | 0.39% | 44 |
|
|
2025
Q2 | $5.13M | Sell |
27,618
-450
| -2% | -$83.6K | 0.32% | 46 |
|
|
2025
Q1 | $5.88M | Sell |
28,068
-36,505
| -57% | -$7.1M | 0.37% | 44 |
|
|
2024
Q4 | $11.5M | Sell |
64,573
-1,280
| -2% | -$235K | 0.74% | 44 |
|
|
2024
Q3 | $13M | Sell |
65,853
-1,025
| -2% | -$191K | 0.79% | 43 |
|
|
2024
Q2 | $11.5M | Sell |
66,878
-820
| -1% | -$136K | 0.74% | 45 |
|
|
2024
Q1 | $12.3M | Buy |
67,698
+16,194
| +31% | +$2.79M | 0.76% | 45 |
|
|
2023
Q4 | $7.98M | Sell |
51,504
-2,050
| -4% | -$299K | 0.52% | 44 |
|
|
2023
Q3 | $7.98M | Sell |
53,554
-975
| -2% | -$143K | 0.54% | 42 |
|
|
2023
Q2 | $7.35M | Sell |
54,529
-739
| -1% | -$108K | 0.48% | 46 |
|
|
2023
Q1 | $8.81M | Sell |
55,268
-14,210
| -20% | -$2.17M | 0.57% | 45 |
|
|
2022
Q4 | $11.2M | Sell |
69,478
-370
| -0.5% | -$56.7K | 0.68% | 43 |
|
|
2022
Q3 | $9.37M | Sell |
69,848
-400
| -0.6% | -$57.4K | 0.65% | 44 |
|
|
2022
Q2 | $10.8M | Buy |
70,248
+1,980
| +3% | +$303K | 0.67% | 42 |
|
|
2022
Q1 | $11.1M | Sell |
68,268
-209,085
| -75% | -$30.4M | 0.65% | 43 |
|
|
2021
Q4 | $37.6M | Sell |
277,353
-2,775
| -1% | -$328K | 2.25% | 17 |
|
|
2021
Q3 | $30.2M | Sell |
280,128
-3,530
| -1% | -$403K | 1.94% | 22 |
|
|
2021
Q2 | $32M | Sell |
283,658
-6,775
| -2% | -$763K | 1.99% | 20 |
|
|
2021
Q1 | $31.4M | Buy |
290,433
+166,690
| +135% | +$17.8M | 1.96% | 21 |
|
|
2020
Q4 | $13.3M | Sell |
123,743
-2,200
| -2% | -$211K | 0.9% | 35 |
|
|
2020
Q3 | $11M | Buy |
125,943
+5,100
| +4% | +$480K | 0.85% | 38 |
|
|
2020
Q2 | $11.9M | Buy |
120,843
+2,500
| +2% | +$220K | 0.95% | 35 |
|
|
2020
Q1 | $9.02M | Sell |
118,343
-182,400
| -61% | -$15.5M | 0.8% | 38 |
|
|
2019
Q4 | $26.6M | Sell |
300,743
-7,500
| -2% | -$623K | 1.72% | 24 |
|
|
2019
Q3 | $23.3M | Sell |
308,243
-3,300
| -1% | -$226K | 1.56% | 24 |
|
|
2019
Q2 | $22.7M | Sell |
311,543
-4,700
| -1% | -$369K | 1.54% | 24 |
|
|
2019
Q1 | $25.5M | Buy |
316,243
+110,775
| +54% | +$9.06M | 1.75% | 22 |
|
|
2018
Q4 | $18.9M | Sell |
205,468
-3,000
| -1% | -$264K | 1.44% | 23 |
|
|
2018
Q3 | $19.7M | Sell |
208,468
-7,500
| -3% | -$711K | 1.32% | 25 |
|
|
2018
Q2 | $20M | Buy |
215,968
+1,525
| +0.7% | +$149K | 1.41% | 25 |
|
|
2018
Q1 | $20.3M | Buy |
214,443
+85,125
| +66% | +$9.35M | 1.46% | 26 |
|
|
2017
Q4 | $12.5M | Sell |
129,318
-4,015
| -3% | -$378K | 0.85% | 38 |
|
|
2017
Q3 | $11.8M | Sell |
133,333
-11,778
| -8% | -$897K | 0.84% | 38 |
|
|
2017
Q2 | $10.5M | Sell |
145,111
-4,000
| -3% | -$269K | 0.72% | 42 |
|
|
2017
Q1 | $9.72M | Buy |
149,111
+31,330
| +27% | +$1.97M | 0.65% | 45 |
|
|
2016
Q4 | $7.38M | Sell |
117,781
-9,996
| -8% | -$610K | 0.47% | 50 |
|
|
2016
Q3 | $8.06M | Buy |
127,777
+30
| +0% | +$1.94K | 0.5% | 46 |
|
|
2016
Q2 | $7.91M | Buy |
127,747
+6,187
| +5% | +$377K | 0.5% | 48 |
|
|
2016
Q1 | $6.94M | Buy |
121,560
+4,500
| +4% | +$251K | 0.48% | 49 |
|
|
2015
Q4 | $6.93M | Sell |
117,060
-4,450
| -4% | -$256K | 0.51% | 48 |
|
|
2015
Q3 | $6.61M | Sell |
121,510
-4,200
| -3% | -$273K | 0.5% | 46 |
|
|
2015
Q2 | $8.45M | Sell |
125,710
-1,575
| -1% | -$103K | 0.57% | 40 |
|
|
2015
Q1 | $7.45M | Sell |
127,285
-11,900
| -9% | -$719K | 0.49% | 47 |
|
|
2014
Q4 | $9.11M | Sell |
139,185
-206,990
| -60% | -$13M | 0.57% | 40 |
|
|
2014
Q3 | $20M | Buy |
346,175
+8,650
| +3% | +$480K | 1.36% | 29 |
|
|
2014
Q2 | $19.1M | Buy |
337,525
+600
| +0.2% | +$31.5K | 1.35% | 26 |
|
|
2014
Q1 | $17.3M | Buy |
336,925
+120,550
| +56% | +$6.09M | 1.28% | 29 |
|
|
2013
Q4 | $11.4M | Buy |
216,375
+59,000
| +37% | +$2.9M | 0.86% | 38 |
|
|
2013
Q3 | $7.04M | Sell |
157,375
-14,250
| -8% | -$632K | 0.58% | 49 |
|
|
2013
Q2 | $7.09M | Buy |
+171,625
| New | +$7.51M | 0.55% | 49 |
|
Other funds holding ABBV
VCM
VPM
Edgar Lomax Company's ABBV Position: Q1 2026 in Review
Edgar Lomax Company increased its AbbVie (ABBV) stake by 236% in Q1 2026, buying an estimated $10.9M and bringing the position to 70,108 shares worth $15.2M. The position accounts for 1.09% of the portfolio, ranked #39.
Edgar Lomax Company first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.6M in Q4 2021. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Edgar Lomax Company held 70,108 shares of AbbVie worth $15.2M as of Q1 2026.
- Edgar Lomax Company bought 49,260 AbbVie shares in Q1 2026, an estimated $10.9M.
- AbbVie made up 1.09% of Edgar Lomax Company's portfolio in Q1 2026, its #39 holding.
- Edgar Lomax Company first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Edgar Lomax Company's AbbVie position peaked at $37.6M in Q4 2021.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.